- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: September 2011
As some might remember this post on genome sequencing. The revolution is already happening. You can read it here. The projected time of sequencing 600 GB of DNA (human genome has 3 GigaBases) might be as fast as 1 week. Where … Continue reading
An interesting essay in New York Times by Eric Manheimer. Link.
New thing on Zenhabits. You can read it here.